This refers to the proportion of total circulating testosterone that is unbound to sex hormone-binding globulin (SHBG) or albumin, representing the biologically active fraction capable of diffusing into target tissues to exert androgenic effects. Clinically, this fraction, often calculated or directly measured, is a more accurate determinant of androgenic status than total testosterone alone. Understanding this fraction is central to assessing true hormonal availability.
Origin
The concept arises from steroid hormone binding dynamics in plasma, where testosterone exists in equilibrium between bound (inactive) and free (active) states. The term ‘fraction’ denotes the ratio of the free component relative to the total measured concentration. This distinction became critical as clinical understanding evolved past simple total hormone assays.
Mechanism
The mechanism involves the equilibrium dynamics governed by the affinity of SHBG for testosterone; higher SHBG concentrations effectively sequester more testosterone, lowering the free fraction even if total levels are normal. Tissues possess receptors only accessible to the unbound form, meaning that while total testosterone might be adequate, low free levels can result in clinical hypogonadal symptoms. Modulating SHBG levels is thus an indirect, yet potent, way to influence androgenic effect.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.